Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.52 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | LGMN | Q99538 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
| ▸ | LTB4R | Q15722 | 5/20 | 0.36 |
| ▸ | LTB4R2 | Q9NPC1 | 4/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.34 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8314473 | 0.91 | CYP4F2 (0.56) | CYP4F2CYP4A11L3MBTL1LGMNTDP1 | |
| SCHEMBL14046828 | 0.85 | CYP4F2 (0.52) | CYP4F2CYP4A11L3MBTL1LGMNTDP1 | |
| SCHEMBL30982179 | 0.85 | CYP4F2 (0.52) | CYP4F2CYP4A11L3MBTL1LGMNTDP1 | |
| SCHEMBL4246764 | 0.85 | CYP4F2 (0.52) | CYP4F2CYP4A11L3MBTL1LGMNTDP1 | |
| SCHEMBL10512434 | 0.80 | CYP4F2 (0.55) | CYP4F2CYP4A11L3MBTL1TDP1CTDSP1 | |
| SCHEMBL10510563 | 0.78 | NFKB1 (0.59) | CYP4F2CYP4A11NFKB1NFKB2RELA | |
| SCHEMBL10635508 | 0.78 | CYP4F2 (0.50) | CYP4F2CYP4A11L3MBTL1TDP1CTDSP1 | |
| SCHEMBL6631393 | 0.77 | CYP4F2 (0.61) | CYP4F2CYP4A11LGMNHSD11B1NFKB1 | |
| SCHEMBL8587477 | 0.77 | LTB4R (0.50) | CYP4F2CYP4A11LTB4RLTB4R2 | |
| SCHEMBL7314503 | 0.76 | TDP1 (0.56) | CYP4F2CYP4A11L3MBTL1TDP1CTDSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1409490-B1 | 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA A|NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY | WYETH CORP (US) | 2006-09-06 | — | — | EP | disclosed |
| EP-1421086-B1 | 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA a|NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY | WYETH CORP (US) | 2006-08-30 | — | — | EP | disclosed |
| EP-1421086-A1 | 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA a]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY | Wyeth (US) | 2004-05-26 | — | — | EP | disclosed |
| EP-1409490-A1 | 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA A]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY | Wyeth (US) | 2004-04-21 | — | — | EP | disclosed |
| US-6541501-B2 | Dopamine autoreceptor agonists | WYETH | 2003-04-01 | — | — | US | disclosed |
| US-6541502-B1 | Treatment of disorders associated with dopamine dysregulation such as schizophrenia | WYETH | 2003-04-01 | — | — | US | disclosed |
| US-20030037701-A1 | 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA[A]-NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY | WYETH | 2003-02-27 | — | — | US | disclosed |
| WO-2003008420-A1 | 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA[A]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY | WYETH (US) | 2003-01-30 | — | — | WO | disclosed |
| WO-2003008419-A1 | 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA[a]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY | WYETH (US) | 2003-01-30 | — | — | WO | disclosed |